|
Market Closed -
NYSE
16:00:03 2026-09-08 EDT
|
5-day change | 1st Jan Change | ||
| 6.050 USD | -0.66% |
|
+3.07% | +14.58% |
| 08-27 | Orion launches share buyback for incentive program | FW |
| 08-10 | Orion License Partner Tenax's Pulmonary Hypertension Drug Fails to Improve Walk Distance in Late-stage Trial | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Specialty Chemicals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 344M | - | - | |||
| 78.29B | |||||
| 38.35B | |||||
| 36.87B | |||||
| 25.1B | |||||
| 22.67B |
- Stock Market
- Stocks
- OEC Stock
- Charts Orion S.A.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
